108 phenotypes from 17 alleles in 18 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Cebpam4443Dajl/Cebpam4443Dajl involves: C3H/HeSnJ * C57BL/6J * SWR	decreased body weight	J:149088
	increased circulating cholesterol level	J:149088
	increased circulating HDL cholesterol level	J:149088
	increased circulating LDL cholesterol level	J:149088
	increased circulating triglyceride level	J:149088
Cebpatm1.1(cre)Touw/Cebpa+ involves: 129/Sv * 129X1/SvJ * C57BL/6	normal hematopoietic system phenotype	J:166620
Cebpatm1.1Gonz/Cebpatm1.1Gonz involves: 129X1/SvJ * C57BL/6	perinatal lethality	J:42995
Cebpatm1Btp/Cebpatm1Btp involves: 129P2/OlaHsd * C57BL/6	no abnormal phenotype detected	J:105554
Cebpatm1Dgt/Cebpatm1Dgt involves: 129S6/SvEvTac	no abnormal phenotype detected	J:94682
Cebpatm1Dgt/Cebpatm1Dgt Tg(Mx1-cre)1Cgn/0 involves: 129S6/SvEvTac * C57BL/6 * CBA	abnormal myelopoiesis	J:94682
	decreased granulocyte number	J:94682
	failure of myelopoiesis	J:94682
	premature death	J:94682
	sepsis	J:94682
Cebpatm1Dgt/Cebpatm1Dgt Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0 involves: 129 * 129S6/SvEvTac * C57BL/6	abnormal pulmonary alveolus epithelial cell morphology	J:105593
	abnormal pulmonary alveolus morphology	J:105593
	abnormal pulmonary alveolus wall morphology	J:105593
	abnormal surfactant secretion	J:105593
	abnormal type II pneumocyte morphology	J:105593
	absent alveolar lamellar bodies	J:105593
	absent type I pneumocytes	J:105593
	absent type II pneumocytes	J:105593
	normal hematopoietic system phenotype	J:105593
	normal liver/biliary system phenotype	J:105593
	neonatal lethality, incomplete penetrance	J:105593
	respiratory distress	J:105593
	respiratory failure	J:105593
Cebpatm1Gjd/Cebpatm1Gjd B6.129S7-Cebpatm1Gjd	absent common myeloid progenitor cells	J:94682
	failure of myelopoiesis	J:94682
Cebpatm1Gjd/Cebpatm1Gjd involves: 129/Sv * 129S7/SvEvBrd * C57BL/6	normal endocrine/exocrine gland phenotype	J:48513
	normal reproductive system phenotype	J:48513
Cebpatm1Gjd/Cebpatm1Gjd involves: 129S7/SvEvBrd * C57BL/6	abnormal energy expenditure	J:28320
	abnormal gluconeogenesis	J:28320
	abnormal glucose homeostasis	J:28320
	abnormal glycogen homeostasis	J:28320
	abnormal hepatocyte morphology	J:28320
	abnormal inguinal fat pad morphology	J:28320
	abnormal lipid homeostasis	J:28320
	abnormal liver morphology	J:28320
	abnormal lung morphology	J:28320
	abnormal pulmonary alveolus morphology	J:105087
	abnormal pulmonary alveolus wall morphology	J:105087
	abnormal surfactant secretion	J:105087
	absent gastric milk in neonates	J:28320
	decreased body weight	J:28320
	decreased brown adipose tissue amount	J:28320
	decreased circulating serum albumin level	J:28320
	decreased liver glycogen level	J:28320
	decreased white adipose tissue amount	J:28320
	normal digestive/alimentary phenotype	J:46862
	hypoglycemia	J:28320
	increased circulating tyrosine level	J:28320
	increased type II pneumocyte number	J:105087
	lethargy	J:28320
	neonatal lethality, complete penetrance	J:28320
	perinatal lethality, incomplete penetrance	J:28320
	slow postnatal weight gain	J:28320
Cebpatm1Gonz/Cebpatm1Gonz Tg(Alb1-cre)1Dlr/0 involves: 129X1/SvJ * FVB/N	increased circulating free fatty acids level	J:93579
Cebpatm1Gonz/Cebpatm1Gonz Tg(KRT5-cre)5132Jlj/0 involves: 129X1/SvJ * C57BL/6 * DBA/2J	increased skin papilloma incidence	J:123139
	increased skin tumor incidence	J:123139
	increased squamous cell carcinoma incidence	J:123139
	increased tumor growth/size	J:123139
	normal integument phenotype	J:123139
Cebpatm1Gonz/Cebpatm1Gonz Tg(KRT14-cre/ERT)20Efu/0 involves: 129X1/SvJ * C57BL/6 * CD-1	epidermal hyperplasia	J:158721
	increased keratinocyte proliferation	J:158721
	normal integument phenotype	J:158721
	thick epidermis	J:158721
Cebpatm1Gonz/Cebpatm1Gonz Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0 involves: 129 * 129X1/SvJ * C57BL/6 * FVB/N	abnormal lung saccule morphology	J:106543
	abnormal lung vasculature morphology	J:106543
	abnormal surfactant secretion	J:106543
	abnormal type I pneumocyte morphology	J:106543
	abnormal type II pneumocyte morphology	J:106543
	absent type I pneumocytes	J:106543
	atelectasis	J:106543
	neonatal lethality, complete penetrance	J:106543
	pulmonary vascular congestion	J:106543
	respiratory distress	J:106543
Cebpatm1Kgx/Cebpatm1Kgx involves: 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal bile canaliculus morphology	J:35795
	abnormal glucose homeostasis	J:35795
	abnormal hepatocyte morphology	J:35795
	abnormal lipid homeostasis	J:35795, J:89611
	abnormal liver morphology	J:35795
	abnormal lung development	J:35795
	abnormal lung interstitium morphology	J:35795
	abnormal pulmonary alveolus morphology	J:35795
	abnormal type II pneumocyte morphology	J:35795
	absent gastric milk in neonates	J:35795
	decreased birth weight	J:35795
	decreased body size	J:35795
	decreased brown adipose tissue amount	J:35795
	decreased liver glycogen level	J:35795
	decreased white adipose tissue amount	J:89611
	flaky skin	J:35795
	hypoglycemia	J:35795
	impaired lung alveolus development	J:35795
	increased litter size	J:35795
	increased type II pneumocyte number	J:35795
	lethargy	J:35795
	neonatal lethality, incomplete penetrance	J:35795
	postnatal growth retardation	J:35795
	postnatal lethality, incomplete penetrance	J:35795
	respiratory distress	J:35795
	respiratory failure	J:35795
	slow postnatal weight gain	J:35795
Cebpatm1Nerl/Cebpatm1Nerl involves: 129P2/OlaHsd * C57BL/6	normal adipose tissue phenotype	J:72330
	normal immune system phenotype	J:72330
	no abnormal phenotype detected	J:72330
Cebpatm1Timc/Cebpatm1Timc Not Specified	decreased circulating glucose level	J:163725
	decreased hepatocyte proliferation	J:163725
	hepatic steatosis	J:163725
	increased circulating alanine transaminase level	J:163725
	increased circulating aspartate transaminase level	J:163725
	increased circulating triglyceride level	J:163725
	increased incidence of tumors by chemical induction	J:163725
Cebpatm2Btp/Cebpatm2Btp B6.129P2-Cebpatm2Btp	abnormal bone marrow cell morphology/development	J:187834
	abnormal definitive hematopoiesis	J:187834
	abnormal myelopoiesis	J:187834
	decreased neutrophil cell number	J:187834
	enlarged spleen	J:187834
	normal hematopoietic system phenotype	J:187834
	increased erythroid progenitor cell number	J:187834
	increased hematopoietic stem cell number	J:187834
Cebpatm2Nerl/Cebpatm2Nerl involves: 129P2/OlaHsd * C57BL/6	abnormal gonadal fat pad morphology	J:72330
	abnormal granulocyte morphology	J:72330
	decreased granulocyte number	J:72330
	decreased white adipose tissue amount	J:72330
	normal immune system phenotype	J:72330
	premature death	J:72330
Cebpatm3Nerl/Cebpatm3Nerl involves: 129P2/OlaHsd * C57BL/6	normal adipose tissue phenotype	J:72330
	normal immune system phenotype	J:72330
Cebpatm4Nerl/Cebpatm4Nerl involves: 129P2/OlaHsd * C57BL/6	abnormal gonadal fat pad morphology	J:72330
	abnormal granulocyte morphology	J:72330
	decreased granulocyte number	J:72330
	decreased white adipose tissue amount	J:72330
	normal immune system phenotype	J:72330
	premature death	J:72330
Cebpatm5Nerl/Cebpatm5Nerl involves: 129P2/OlaHsd * C57BL/6	abnormal hepatocyte morphology	J:120098
	abnormal liver physiology	J:120098
	normal adipose tissue phenotype	J:120098
	increased liver triglyceride level	J:120098
	normal liver/biliary system phenotype	J:120098
Cebpatm6Nerl/Cebpatm6Nerl involves: 129P2/OlaHsd * C57BL/6	abnormal circulating insulin level	J:120098
	abnormal liver physiology	J:120098
	normal adipose tissue phenotype	J:120098
	decreased adipocyte glucose uptake	J:120098
	decreased liver glycogen level	J:120098
	decreased muscle cell glucose uptake	J:120098
	normal hematopoietic system phenotype	J:120098
	impaired glucose tolerance	J:120098
	increased circulating glucose level	J:120098
	normal respiratory system phenotype	J:120098
Cebpatm8.1Nerl/Cebpa+ involves: 129P2/OlaHsd * BALB/cJ * C57BL/6	abnormal common myeloid progenitor cell morphology	J:136134
Cebpatm8.1Nerl/Cebpatm8.1Nerl involves: 129P2/OlaHsd * BALB/cJ * C57BL/6	abnormal common myeloid progenitor cell morphology	J:136134
	abnormal definitive hematopoiesis	J:136134
	abnormal granulocyte morphology	J:136134
	abnormal leukocyte morphology	J:136134
	abnormal myeloid leukocyte morphology	J:136134
	decreased granulocyte number	J:136134
	decreased hematocrit	J:136134
	decreased hepatocyte number	J:136134
	decreased monocyte cell number	J:136134
	decreased neutrophil cell number	J:136134
	enlarged spleen	J:136134
	extramedullary hematopoiesis	J:136134
	hypoglycemia	J:136134
	increased leukemia incidence	J:136134
	liver failure	J:136134
	liver inflammation	J:136134
	postnatal lethality, incomplete penetrance	J:136134
	premature death	J:136134